Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis

Journal of Dermatological Treatment

Volumn 23, Issue 2, 2012, Pages 112-115

  Nakamura, Satoshi ^a,b   Takeda, Keiko ^a   Hashimoto, Yoshio ^b   Nishi, Kaoru ^a   Takahashi, Hidetoshi ^a   Mizumoto, Toshihiro ^b   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Asahikawa Kousei Hospital   (Japan)

Author keywords

Atopic dermatitis; Ciclosporin; Pre prandial administration

Indexed keywords

CYCLOSPORIN; EMOLLIENT AGENT; GLUCOCORTICOID; PREDNISOLONE; TACROLIMUS;

AREA UNDER THE CURVE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MONITORING; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; PREPRANDIAL ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; REVIEW; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADULT; AREA UNDER CURVE; CYCLOSPORINE; DERMATITIS, ATOPIC; DRUG MONITORING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TIME FACTORS;

EID: 84858211261     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2010.507702     Document Type: Review

References (13)

1. Furue M, editor. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis, 2008 edition. Japan: The Japanese Dermatological Association; 2009. p. 1515-1534.
2. Sowden JM, Berth-Jones J, Ross JS, Montley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338:137-140.
3. Van Joost T, Heule F, Korstanje M, Van Den Broek MJTB, Stenveld HJ, Van Vloten WA. Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. Br J Dermatol. 1994;130:634-640. (Pubitemid 24204701)
4. Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, et al. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: A comparison of two dosage regimens. Br J Dermatol. 1996;135(suppl 48):15-20. (Pubitemid 26294725)
5. Berth-Jones J, Graham-Brown RA, Marks R, Camp RDR, English JSC, Freeman K, et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol. 1997;136:76-81. (Pubitemid 27016179)
6. Czech W, Brautigam M, Weidinger G, Scopf E, and ADOPT study group. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol. 2000;42:653-659. (Pubitemid 30479891)
7. Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: A systematic review. Acta Derm Venerol. 2007;87:100-111. (Pubitemid 46521989)
8. Hashizume H, Ito T, Yagi H, Takikawa M, Kageyama H, Furukawa F, et al. Efficacy and safety for pre-prandial versus post-prandial administration of low-dose cyclosporin micro-emulsion (Neoral) in patients with psoriasis vulgaris. J Dermatol. 2007;34:430-434. (Pubitemid 46956586)
9. Umezawa Y, Mabuchi T, Ozawa A. Pre-prandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis. Int J Dermatol. 2007;46:880-882. (Pubitemid 47162797)
10. Brandt C, Pavlovic V, Radbruch A, Worm M, Baumgrass R. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy. 2009;64:1588-1596.
11. Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, et al. More stable and reliable pharmacokinetics with pre-prandial administration of cyclosporine compared with post-prandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy. 2005;25:52-58. (Pubitemid 40054033)
12. Shirai S, Yasuda T, Tsuchida H, Kuboshima S, Konno Y, Shima Y, et al. Pre-prandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clin Exp Nephrol. 2009;13:123-129.
13. Naito M, Takei T, Eguchi A, Uchida K, Tsuchiya K, Nitta K. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome. Internal Med. 2008;47: 1567-1572.